Annexes II, VII, VIII, IX and X to Regulation (EC) No 999/2001 are amended as follows:
Annex II is amended as follows:
Points 1 and 2 of Chapter B are replaced by the following:
The risk analyses shall comprise an entry assessment and an exposure assessment.
2.1. The entry assessment shall consist of assessing the likelihood that the BSE agent has either been introduced into the country or region via commodities potentially contaminated with a BSE agent, or is already present in the country or region.
The following risk factors shall be taken into account:
the presence or absence of the BSE agent in the country or region and, if the agent is present, its prevalence based on the outcome of surveillance activities;
the production of meat-and-bone meal or greaves from the BSE indigenous ruminant population;
imported meat-and-bone meal or greaves;
imported bovine and ovine and caprine animals;
imported animal feed and feed ingredients;
imported products of ruminant origin for human consumption, which may have contained tissues listed in point 1 of Annex V and may have been fed to bovine animals;
imported products of ruminant origin for in vivo use in bovine animals.
2.2. Special eradication schemes, surveillance and other epidemiological investigations (especially surveillance for BSE conducted on the bovine animals population) relevant to the risk factors listed in point 2.1 should be taken into ac-count in carrying out the entry assessment.’
In point 3 of Chapter D, Table 2 is replaced by the following:
Points targets for country or region
Adult bovine animals population size
(24 months and older)
Type A surveillance | Type B surveillance
> 1000000 | 300000 | 150000
900001-1000000 | 214600 | 107300
800001-900000 | 190700 | 95350
700001-800000 | 166900 | 83450
600001-700000 | 143000 | 71500
500001-600000 | 119200 | 59600
400001-500000 | 95400 | 47700
300001-400000 | 71500 | 35750
200001-300000 | 47700 | 23850
100001-200000 | 22100 | 11500
90001-100000 | 19900 | 9950
80001-90000 | 17700 | 8850
70001-80000 | 15500 | 7750
60001-70000 | 13000 | 6650
50001-60000 | 11000 | 5500
40001-50000 | 8800 | 4400
30001-40000 | 6600 | 3300
20001-30000 | 4400 | 2200
10001-20000 | 2100 | 1050
9001-10000 | 1900 | 950
8001-9000 | 1600 | 800
7001-8000 | 1400 | 700
6001-7000 | 1200 | 600
5001-6000 | 1000 | 500
4001-5000 | 800 | 400
3001-4000 | 600 | 300
2001-3000 | 400 | 200
1001-2000 | 200 | 100’
In Annex VII, the first paragraph in point 2.2.1 of Chapter B is replaced by the following:
‘If BSE cannot be excluded after the results of the secondary molecular testing carried out in accordance with the methods and protocols set out in Annex X, Chapter C, point 3.2(c) (ii), the killing and complete destruction, without delay, of all animals, embryos and ova identified by the inquiry referred to in the second to fifth indents of point 1(b).’
In Annex VIII, Section A of Chapter A is amended as follows:
In point 1.2, paragraph (g) is replaced by the following:
‘(g) only the following ovine and caprine embryos/ova may be introduced:
embryos/ova from donor animals which have been kept since birth in a Member State with a negligible risk of classical scrapie, or in a holding with a negligible or a controlled risk of classical scrapie, or which meet the following requirements:
they are permanently identified to enable trace back to their holding of birth
they have been kept since birth in holdings in which no case of classical scrapie has been confirmed during their residency
they showed no clinical sign of classical scrapie at the time of embryo/ova collection;
ovine embryos/ova carrying at least one ARR allele.’
In point 1.3, paragraph (g) is replaced by the following:
‘(g) only the following ovine and caprine embryos/ova may be introduced:
embryos/ova from donor animals which have been kept since birth in a Member State with a negligible risk of classical scrapie, or in a holding with a negligible or a controlled risk of classical scrapie, or which meet the following requirements:
they are permanently identified to enable trace back to their holding of birth
they have been kept since birth in holdings in which no case of classical scrapie has been confirmed during their residency
they showed no clinical sign of classical scrapie at the time of embryo/ova collection;
ovine embryos/ova carrying at least one ARR allele.’
In point 2, the following point 3 is added:
‘2.3. The Member States or zone of the Member State with a negligible risk for classical scrapie are the following:
Austria.’
Point 3.2 is replaced by the following:
‘3.2. The national scrapie control programmes of the following Member States are hereby approved:
Denmark
Finland
Sweden.’
In point 4.2, paragraph (e) is replaced by the following:
‘(e) in the case of ovine embryos, be carrying at least one ARR allele.’
In Annex IX, point (ii) of point 2 of Chapter H is replaced by the following:
‘(ii) in the case of ovine embryos, the embryos carry at least one ARR allele.’
Annex X is replaced by the following: